Clinical trial / 2009
Beta 1,3/1,6 glucan supplementation reduced URTI symptoms and improved mood states in marathon runners following a race.
A double-blind, placebo-controlled study evaluated the effects of 250 mg or 500 mg daily of BETA 1,3/1,6 GLUCAN compared to placebo over a 4-week post-marathon period in 75 runners. Participants completed the Profile of Mood State (POMS) assessment and a health log measuring URTI symptoms at 2 and 4 weeks. Over the 4-week study, subjects taking either dose of beta-glucan reported significantly fewer URTI symptoms, better overall health, decreased confusion, fatigue, tension, and anger, and increased vigor compared to placebo.
- Study type
- Placebo-controlled, double-blind trial
- Who was studied
- 75 marathon runners (35 men, 40 women, aged 18-53 years, mean age 36 ± 9)
- What was measured
- Upper-respiratory tract symptoms (URTI) and mood state (POMS)
THE PAPER
Effect of BETA 1, 3/1, 6 GLUCAN on Upper Respiratory Tract Infection Symptoms and Mood State in Marathon Athletes.
Talbott S, Talbott J. J Sports Sci Med, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.